Steven Hill
Chief Executive Officer at NEWHYDROGEN, INC.
Net worth: - $ as of 2024-03-30
Profile
Steven Hill is currently the Chief Executive Officer & Director at NewHydrogen, Inc. Prior to his current position, he served as the Managing Member at Hill Investments LLC from 2016 to 2023.
Before that, he worked as a Regional Account Manager at Relypsa, Inc. from 2015 to 2021.
Mr. Hill holds an MBA from Instituto de Empresa SL and an undergraduate degree from Utah Valley University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NEWHYDROGEN INC
0.00% | 2024-03-14 | 3 ( 0.00% ) | 0 $ | 2024-03-30 |
Steven Hill active positions
Companies | Position | Start |
---|---|---|
NEWHYDROGEN, INC. | Chief Executive Officer | 2023-06-14 |
Former positions of Steven Hill
Companies | Position | End |
---|---|---|
Hill Investments LLC | Corporate Officer/Principal | 2023-01-31 |
RELYPSA INC | Comptroller/Controller/Auditor | 2021-09-30 |
Training of Steven Hill
Instituto de Empresa SL | Masters Business Admin |
Utah Valley University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
NewHydrogen, Inc. | |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Hill Investments LLC |
- Stock Market
- Insiders
- Steven Hill